Pacific Compounding Pharmacy & Consultations recalls

FDA enforcement reports naming Pacific Compounding Pharmacy & Consultations Inc as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Apr 10, 2019

Severity

Apr 10, 2019Cefuroxime 10mg/mL INJ 0Drug · Pacific Compounding Pharmacy & Consultations IncPresence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopperClass II